News

How a platform makes big data usable for medicine

MedWatch supports medical research by collecting real-world evidence.

Handelsblatt
18.10.2023

Real-world evidence (RWE) is seen as a pioneering method in medicine for obtaining clear results on the risk-benefit profile of drug therapies. Currently, data collection is mainly limited to registry data stored by health insurance companies for billing purposes. It is argued that there is a need for more comprehensive, standardized data collection covering all aspects of drug therapies. As part of this discussion, MEDIKURA Digital Health GmbH, which has developed a unique digital real-world evidence database, will be presented. This innovative platform allows patients to report back their experiences with medication in a standardized way and collects high-quality data from real-world care practice regarding the effects and side effects of drug therapies.

The data generated by MEDIKURA's ImpactMonitor is available in digital form, which makes it easier and cheaper to access and structure. The standardized data sets are available to all affected patients, medical professionals and research companies and support the fast, user-friendly and representative risk-benefit assessment for new drug approvals. This platform provides an important basis for research institutes and drug manufacturers to check the effects and side effects of their products in real time. It also enables monitoring over longer periods of time that are not covered by randomized controlled trials. This contributes significantly to precision medicine, which will become increasingly important in the future, for example in the development of gender- or age-specific drugs.

MedWatcher

Contact

E-mail

Contact for companies:

fachkreise@xo-life.com

Press

Our press contact for inquiries:

presse@medwatcher.io

Office

We can also be reached by classical means:

XO Life Ltd.
Agnes Pockels Arc 180992 Munich

The MedWatcher is in demand.

Stay up to date.

Two million euros for XO Life GmbH

XO Life raises over 2 million euros for the expansion of the Patient Insights platform.
Read article
PressBOX
18.10.23

How an innovative digital platform supports precision medicine

XO Life introduces an innovative communication platform.
Read article
World
18.10.23

One night, ten pitches: These start-ups present themselves

MedWatcher presented the benefits and features at Pitch Night 2023.
Read article
en:hub
18.10.23

Position yourself and your pharmacy as a health advisor with MedWatcher

MedWatcher and "FRAG DIE APOTHEKE" connect end customers, pharmacists and the pharmaceutical industry.
Read article
TheDigitalPharmacy
18.10.23

Medwatcher: Instagram for patients

MedWatcher, the "Instagram for Patient:ins," provides a platform for reliable drug information.
Read article
Pharmacy adhoc
18.10.23

MedWatcher creates access to valuable feedback from cancer patients

MedWatcher, in cooperation with the EORTC, gives cancer patients access to standardized questionnaires.
Read article
PRESSEPortal
18.10.23

MedWatcher: Patient information for research

MedWatcher and EORTC collaborate to support cancer patients and research through real-world data.
Read article
Pharma Relations
18.10.23

Patient platform MedWatcher wants to cooperate with pharmacies

MedWatcher partners with "Ask the Pharmacy" to provide specialized health information.
Read article
German Pharmacist Newspaper
18.10.23